Cargando…

Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved

Non-steroidal anti-inflammatory drugs (NSAIDs), the most commonly prescribed and consumed medicines worldwide, are the main triggers of drug hypersensitivity reactions (DHRs). The underlying mechanisms of NSAID-DHRs may be related to COX-1 inhibition (cross-hypersensitivity reactions, CRs) or to imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Sánchez, Natalia, Doña, Inmaculada, Bogas, Gador, Salas, María, Testera, Almudena, Cornejo-García, José A., Torres, María J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212440/
https://www.ncbi.nlm.nih.gov/pubmed/32425774
http://dx.doi.org/10.3389/fphar.2020.00503
_version_ 1783531621579751424
author Pérez-Sánchez, Natalia
Doña, Inmaculada
Bogas, Gador
Salas, María
Testera, Almudena
Cornejo-García, José A.
Torres, María J.
author_facet Pérez-Sánchez, Natalia
Doña, Inmaculada
Bogas, Gador
Salas, María
Testera, Almudena
Cornejo-García, José A.
Torres, María J.
author_sort Pérez-Sánchez, Natalia
collection PubMed
description Non-steroidal anti-inflammatory drugs (NSAIDs), the most commonly prescribed and consumed medicines worldwide, are the main triggers of drug hypersensitivity reactions (DHRs). The underlying mechanisms of NSAID-DHRs may be related to COX-1 inhibition (cross-hypersensitivity reactions, CRs) or to immunological recognition (selective reactions, SRs), being the latter remarkably less studied. SRs include those usually appearing within the first hour after drug intake (single-NSAID-induced urticaria/angioedema or anaphylaxis, SNIUAA), and those usually occurring more than 24 h after (single-NSAID-induced delayed reactions, SNIDR). We have evaluated the largest series of patients with SRs, analyzing the number of episodes and drugs involved, the latency for reaction onset, the clinical entities, among other variables, as well as the value of available diagnostic methods. Globally, pyrazolones and arylpropionics were the most frequent culprits (39.3% and 37.3%, respectively). Pyrazolones were the most frequent triggers in SNIUAA and arylpropionics in SNIDR. Urticaria was the most common clinical entity in SNIUAA (42.4%) followed by anaphylaxis (33.3%); whereas SNIDR induced mostly fixed drug eruption (41.1%) and maculopapular exanthema (32.6%). The percentage of patients diagnosed by clinical history was higher in SNIUAA compared with SNIDR (62.7% versus 35.3%, p = 0.00015), whereas the percentage of those diagnosed by skin tests was higher in SNIDR than in SNIUAA (47.1% versus 22.8%, p = 0.00015). Drug provocation test with the culprit was performed in 67 SNIUAA (14.5%) and in 9 SNIDR (17.6%) patients. Our results may be of interest not only for allergologists but also for other clinicians dealing with these drugs, and can be useful for the correct identification of subjects experiencing DHRs to NSAIDs, and for avoiding mislabeling. Moreover, as NSAIDs are highly consumed worldwide, our results may be of interest for evaluating other populations exposed to these drugs.
format Online
Article
Text
id pubmed-7212440
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72124402020-05-18 Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved Pérez-Sánchez, Natalia Doña, Inmaculada Bogas, Gador Salas, María Testera, Almudena Cornejo-García, José A. Torres, María J. Front Pharmacol Pharmacology Non-steroidal anti-inflammatory drugs (NSAIDs), the most commonly prescribed and consumed medicines worldwide, are the main triggers of drug hypersensitivity reactions (DHRs). The underlying mechanisms of NSAID-DHRs may be related to COX-1 inhibition (cross-hypersensitivity reactions, CRs) or to immunological recognition (selective reactions, SRs), being the latter remarkably less studied. SRs include those usually appearing within the first hour after drug intake (single-NSAID-induced urticaria/angioedema or anaphylaxis, SNIUAA), and those usually occurring more than 24 h after (single-NSAID-induced delayed reactions, SNIDR). We have evaluated the largest series of patients with SRs, analyzing the number of episodes and drugs involved, the latency for reaction onset, the clinical entities, among other variables, as well as the value of available diagnostic methods. Globally, pyrazolones and arylpropionics were the most frequent culprits (39.3% and 37.3%, respectively). Pyrazolones were the most frequent triggers in SNIUAA and arylpropionics in SNIDR. Urticaria was the most common clinical entity in SNIUAA (42.4%) followed by anaphylaxis (33.3%); whereas SNIDR induced mostly fixed drug eruption (41.1%) and maculopapular exanthema (32.6%). The percentage of patients diagnosed by clinical history was higher in SNIUAA compared with SNIDR (62.7% versus 35.3%, p = 0.00015), whereas the percentage of those diagnosed by skin tests was higher in SNIDR than in SNIUAA (47.1% versus 22.8%, p = 0.00015). Drug provocation test with the culprit was performed in 67 SNIUAA (14.5%) and in 9 SNIDR (17.6%) patients. Our results may be of interest not only for allergologists but also for other clinicians dealing with these drugs, and can be useful for the correct identification of subjects experiencing DHRs to NSAIDs, and for avoiding mislabeling. Moreover, as NSAIDs are highly consumed worldwide, our results may be of interest for evaluating other populations exposed to these drugs. Frontiers Media S.A. 2020-04-21 /pmc/articles/PMC7212440/ /pubmed/32425774 http://dx.doi.org/10.3389/fphar.2020.00503 Text en Copyright © 2020 Pérez-Sánchez, Doña, Bogas, Salas, Testera, Cornejo-García and Torres http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Pérez-Sánchez, Natalia
Doña, Inmaculada
Bogas, Gador
Salas, María
Testera, Almudena
Cornejo-García, José A.
Torres, María J.
Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved
title Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved
title_full Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved
title_fullStr Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved
title_full_unstemmed Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved
title_short Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved
title_sort evaluation of subjects experiencing allergic reactions to non-steroidal anti-inflammatory drugs: clinical characteristics and drugs involved
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212440/
https://www.ncbi.nlm.nih.gov/pubmed/32425774
http://dx.doi.org/10.3389/fphar.2020.00503
work_keys_str_mv AT perezsancheznatalia evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved
AT donainmaculada evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved
AT bogasgador evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved
AT salasmaria evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved
AT testeraalmudena evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved
AT cornejogarciajosea evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved
AT torresmariaj evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved